Published in Am J Hypertens on May 01, 1991
Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol (2009) 2.13
Association between hypertension and fragility fracture: a longitudinal study. Osteoporos Int (2013) 0.92
Lower bone mineral content in hypertensive compared with normotensive overweight Latino children and adolescents. Am J Hypertens (2007) 0.77
Meta-analysis of hypertension and osteoporotic fracture risk in women and men. Osteoporos Int (2017) 0.75
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
Acute renal failure due to nontraumatic rhabdomyolysis. Ann Intern Med (1976) 3.47
Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore) (1976) 3.11
A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab (1984) 2.38
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int (2006) 2.31
Biologic effects of transdermal estradiol. N Engl J Med (1986) 2.24
Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med (1981) 2.00
Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int (1973) 1.88
Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med (1995) 1.80
A new semiautomatic method for quantitative static and dynamic bone histology. Calcif Tissue Int (1982) 1.78
Effect of NaCl infusion on urinary Ca++ and Mg++ during reduction in their filtered loads. Am J Physiol (1967) 1.72
Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. N Engl J Med (1968) 1.66
Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol (1982) 1.66
Physiological changes at parturition and their relationship to metabolic disorders. J Dairy Sci (1997) 1.62
Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem J (1979) 1.58
Treatment of renal anemia with recombinant human erythropoietin. Am J Nephrol (1989) 1.50
Effect of parathyroid hormone on rat heart cells. J Clin Invest (1981) 1.50
Antidiuretic principle in tuberculous lung tissue of a patient with pulmonary tuberculosis and hyponatremia. Ann Intern Med (1970) 1.46
Effect of dietary sodium intake on intracellular calcium in lymphocytes of salt-sensitive hypertensive patients. Am J Hypertens (1992) 1.45
Study of intestinal absorption of calcium in patients with renal failure. Kidney Int (1973) 1.45
Disparate prognosis of thrombotic microangiopathy in HIV-infected patients with and without AIDS. Am J Nephrol (1996) 1.44
Amlodipine prevents and reverses the elevation in [Ca2+]i and the impaired phagocytosis of PMNL of diabetic rats. Nephrol Dial Transplant (1997) 1.44
changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms. J Clin Invest (1972) 1.39
On the mechanism of hypophosphatemia during acute hyperventilation: evidence for increased muscle glycolysis. Miner Electrolyte Metab (1983) 1.39
Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens (1996) 1.38
Quantitative bone histology in 84 normal American subjects. Micromorphometric analysis and evaluation of variance in iliac bone. Calcif Tissue Int (1982) 1.36
Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications. Am J Kidney Dis (1999) 1.35
Vascular calcification and peripheral necrosis in a renal transplant recipient. Reversal of lesions following subtotal parathyroidectomy. Am J Med (1970) 1.33
The influence of extracellular volume expansion on renal phosphate reabsorption in the dog. J Clin Invest (1969) 1.26
The physicochemical state and renal handling of divalent ions in chronic renal failure. Arch Intern Med (1969) 1.26
1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure. Ann Intern Med (1974) 1.25
Renal osteodystrophy; some therapeutic consideration relative to long-term dialysis and transplantation. Arch Intern Med (1969) 1.24
Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension (1991) 1.23
Divalent ion metabolism and osteodystrophy in chronic renal failure. Yale J Biol Med (1967) 1.23
Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure. Arch Intern Med (1976) 1.23
Quantitation of vitamin D and its metabolites and their plasma concentrations in five species of animals. Anal Biochem (1981) 1.22
Abnormalities of the musculoskeletal system in hemodialysis patients. Semin Arthritis Rheum (1975) 1.21
Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci U S A (2000) 1.20
Microradiographic studies of bone in renal osteodystrophy. Arch Intern Med (1969) 1.19
Acute renal failure during intermittent rifampicin therapy. Nephron (1973) 1.19
Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens (1998) 1.19
Effect of parathyroid hormone on erythropoiesis. J Clin Invest (1981) 1.18
Effect of chronic bile duct obstruction on renal handling of salt and water. J Clin Invest (1972) 1.18
25-Hydroxyvitamin D3 26,23-lactone: a new in vivo metabolite of vitamin D. Biochemistry (1979) 1.18
Antidiuretic principle in malignant tumor extracts from patients with inappropriate ADH syndrome. J Clin Endocrinol Metab (1968) 1.17
A sensitive hydroosmotic toad bladder assay. Affinity and intrinsic activity of neurohypophyseal peptides. J Gen Physiol (1968) 1.17
The clinical spectrum of renal vein thrombosis: acute and chronic. Am J Med (1980) 1.16
Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure. J Clin Endocrinol Metab (1986) 1.16
Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int (1982) 1.15
Inorganic phosphate treatment of hypercalcemia. Arch Intern Med (1968) 1.15
Regulation of L-selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone. J Leukoc Biol (1995) 1.15
The thyroid in end-stage renal disease. Medicine (Baltimore) (1988) 1.15
Task complexity in emergency medical care and its implications for team coordination. LOTAS Group. Level One Trauma Anesthesia Simulation. Hum Factors (1996) 1.14
A limited renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens (1998) 1.13
The determination of 24,25-dihydroxyvitamin D and 25,26-dihydroxyvitamin D in plasma from normal and nephrectomized man. J Lab Clin Med (1979) 1.13
The problem and unanswered questions. Renal osteodystrophy, soft tissue calcification, and distrubed divalent ion metabolism in chronic renal failure. Arch Intern Med (1969) 1.12
Production of angiotensinogen and renin-like activity by rabbit proximal tubular cells in culture. Kidney Int (1991) 1.12
Curable hypertension with unilateral hydronephrosis. Studies on the role of circulating renin. Ann Intern Med (1977) 1.11
Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int (1981) 1.11
Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency. J Clin Endocrinol Metab (1985) 1.11
Changes in serum and urinary calcium during phosphate depletion: studies on mechanisms. J Clin Invest (1970) 1.10
Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest (1985) 1.10
Ca(2+)-ATPase protein expression in mammary tissue. Am J Physiol Cell Physiol (2000) 1.10
Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens (1994) 1.10
Bilateral renal cortical necrosis in two patients with Neisseria meningitidis sepsis. Am J Nephrol (1991) 1.10
Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone. J Clin Invest (1974) 1.10
Effects and interactions of 24R,25(OH)2D3 and 1,25(OH)2D3 on bone. Am J Physiol (1980) 1.10
Temperature dependence of vasopressin action on the toad bladder. J Gen Physiol (1972) 1.09
Central nervous system pH in uremia and the effects of hemodialysis. J Clin Invest (1976) 1.08
Renal biopsy-related hemorrhage: frequency and comparison of CT and sonography. J Comput Assist Tomogr (1987) 1.08
The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. N Engl J Med (1980) 1.08
Evidence for suppression of parathyroid gland activity by hypermagnesemia. J Clin Invest (1970) 1.07
Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int (1997) 1.07
Persistent hypercalcemia after successful renal transplantation. Nephron (1976) 1.07
Disordered calcium and phosphorus metabolism during maintenance hemodialysis. Correlation of clinical, roentgenographic and biochemical changes. Am J Med (1971) 1.07
Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension (1994) 1.07
Clonidine, a centrally acting sympathetic inhibitor, as monotherapy for mild to moderate hypertension. Am J Cardiol (1982) 1.06
Renal bicarbonate wasting during phosphate depletion. A possible cause of altered acid-base homeostasis in hyperparathyroidism. J Clin Invest (1973) 1.06
Intestinal calcium absorption in patients with hyperthyroidism. J Clin Endocrinol Metab (1980) 1.06
Unilateral breast enlargement secondary to hemodialysis arteriovenous fistula and subclavian vein occlusion. Nephron (1993) 1.05
Methicillin nephritis. Medicine (Baltimore) (1977) 1.05
Impaired 24,25-dihydroxyvitamin D production in anephric human and pig. J Clin Invest (1981) 1.05
Estrogen replacement therapy by transdermal estradiol administration. Am J Obstet Gynecol (1983) 1.05
Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes. J Clin Invest (1975) 1.04
Hyponatremia in hospitalized patients with the acquired immunodeficiency syndrome (AIDS) and the AIDS-related complex. Am J Med (1993) 1.04
Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation. Arch Intern Med (1969) 1.04
Threshold and receptor reserve in the action of neurohypophyseal peptides. A study of synergists and antagonists of the hydroosmotic response of the toad urinary bladder. J Gen Physiol (1970) 1.04
Contrasting effects of exogenous 1,25-dihydroxyvitamin D [1,25-(OH)2D] versus endogenous 1,25-(OH)2D, induced by dietary calcium restriction, on vitamin D receptors. Endocrinology (1990) 1.03
Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. J Clin Invest (1976) 1.03
Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy. Kidney Int (1995) 1.02
Blood pressure effects of acute hypercalcemia. Studies in patients with chronic renal failure. Ann Intern Med (1972) 1.02
Primary hyperparathyroidism in patients with breast carcinoma. Arch Surg (1970) 1.02
25-OHD3-26,23-lactone: a metabolite of vitamin D3 that is 5 times more potent than 25-OHD3 in the rat plasma competitive protein binding radioassay. Biochem Biophys Res Commun (1979) 1.02
Divalent ion metabolism in patients with acute renal failure: studies on the mechanism of hypocalcemia. Kidney Int (1974) 1.02